Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Acta Physiologica (Oxford, England)|January 13, 2025
IgE and cardiac diseaseScott P Levick
Heart, Lung & Circulation|September 13, 2018
Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac FibroblastsScott P Levick, David R Soto-Pantoja, Jianli Bi, et al.
British Journal of Pharmacology|April 25, 2026
Neurokinin-1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic miceAlexander Widiapradja, Heather Connery, Brody J Helmick, et al.
Scientific Reports|July 31, 2019
Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic HeartAlexander Widiapradja, Edward J Manteufel, Heather M Dehlin, et al.
International Journal of Cardiology|November 30, 2013
Substance P in heart failure: the good and the badHeather M Dehlin, Scott P Levick
Heart Failure Reviews|April 17, 2013
Could interferon-gamma be a therapeutic target for treating heart failure?Scott P Levick, Paul H Goldspink
Advances in Pharmacology (San Diego, Calif.)|June 6, 2022
Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertensionPrasad Chunduri, Shrey A Patel, Scott P Levick
American Journal of Physiology. Heart and Circulatory Physiology|February 20, 2007
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failureGregory L Brower, Scott P Levick, Joseph S Janicki
Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada|May 11, 2012
Alterations in cardiac structure and function in a murine model of chronic alcohol consumptionBrittany A Law, Scott P Levick, Wayne E Carver
Pageof 6